Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7.00M | $234.0M | 15.32% | -- | 2026-06-30 |
| TRV GP V, LLC | 6.22M | $208.0M | 13.61% | -- | 2026-06-30 |
| Driehaus Capital Management LLC | 4.43M | $148.0M | 9.71% | +37.5K | 2026-06-30 |
| TRV GP VI, LLC | 4.21M | $141.0M | 9.22% | -- | 2026-06-30 |
| SAMSARA BIOCAPITAL, LLC | 3.15M | $105.0M | 6.90% | -- | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 3.06M | $102.0M | 6.71% | +156.3K | 2026-06-30 |
| BlackRock, Inc. | 1.93M | $64.0M | 4.23% | +109.9K | 2026-06-30 |
| Siren, L.L.C. | 1.90M | $63.0M | 4.16% | -100.0K | 2026-06-30 |
| Avoro Capital Advisors LLC | 1.34M | $44.0M | 2.93% | -- | 2026-06-30 |
| Jupiter Topco LLC | 1.31M | $43.0M | 2.86% | -- | 2026-06-30 |
